Achieving High Performance Study Start-up: An Inside Look at GSK

Life Sciences, Clinical Trials,
  • Thursday, July 09, 2020

Study start-up is a critical component of the end-to-end trial process, yet many clinical operations teams still rely on manual trackers and stand-alone disconnected technology to manage and monitor site selection, activation and greenlight progress.

What if you could easily share start-up documentation, workflows and data across TMF and CTMS processes without any manual data entry or complex integrations? How much time could you save if start-up content was automatically filed in your TMF? A single source of truth is achievable by unifying clinical operations to improve control, visibility and efficiency – and selecting a truly unified technology platform is imperative.

GSK will share insights about their journey to faster study start-up – from drivers for change to the technology evaluation process and how a unified clinical operating environment improves trial execution of critical start-up business processes.



Ashley Davidson, Director, Vault Study Startup, Veeva Systems

Ashley Davidson brings 18 years of clinical research experience to her role as director of Vault Study Startup. At Veeva, her primary focus is building a best-of-breed site activation application, ensuring market success and positive customer adoption and leading the industry with innovation. Before joining Veeva, Ashley spent over 14 years in executive management-level positions overseeing global study start-up (SSU) groups of mid-size and large contract research organizations (CROs), as well as led the strategy and customer success at several study start-up technology organizations. She holds a Bachelor of Arts in English from the University of North Carolina at Chapel Hill.

Message Presenter

Jess Robinson, Director of Study Startup, GSK

Jess Robinson has over 10 years of experience in clinical research across different therapeutic areas and study phases, holding various roles at Novartis, Roche, and GSK. Currently a director of study start-up at GSK, Jess is responsible for defining and leading the global study start-up strategy and ensuring on-time delivery of first subject, first visit. Jess is passionate about driving innovative ways of working, coaching and development to optimize study start-up processes.

Message Presenter

Who Should Attend?

This webinar will appeal to senior professionals including:

  • Head of Study Start-Up
  • VP of Site Operations
  • Director of Clinical Trials
  • Study Start-Up Specialist
  • Clinical Trial Specialist
  • Clinical Trial Associate (CTA) / Clinical Research Associate (CRA)
  • Study Manager
  • Site Activation Lead
  • Head of Trial Master File Operations
  • Director of Trial Master File
  • VP of TMF Operations

What You Will Learn

In this webinar participants will learn:

  • The key drivers to look for in transforming your study start-up technology
  • How the steps to execute start-up business processes (e.g., site greenlight) can be drastically reduced and improved
  • How improved start-up performance impacts downstream clinical operations performance
  • Tips to distinguish truly unified clinical platforms from disconnected technology that requires integration across study start-up, TMF, CTMS, and other clinical systems

Xtalks Partner


Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 700 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account